StreetAlpha
13F holdings · Q2 2026

Nextech Invest

Zurich, V8 · files as Nextech Invest Ltd.
Holdings as of Jun 30, 2026Filed Aug 14, 2026Next filing due Nov 16, 2026CIK 1595430

Nextech Invest reported 15 stocks worth $2.1B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are RVMD (67.5%), PBLS (6.1%) and RLAY (6.0%). Compared with Q1 2026, the fund opened new positions in PBLS and ENGN, added to RLAY, GLUE and ARVN, trimmed TYRA and sold out of TNGX, CGEM and SPRY.

Reported value$2.1B+48.3% vs last quarter
Stocks held152 new · 4 sold out
Top 5 weight89.7%very concentrated
Turnover18%of the portfolio changed
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 6 qtrsHeld
1
RVMD
Revolution Medicines Inc
$1.4B67.5%7.6MNo change6 of 6
2
PBLS
Parabilis Medicines Inc Com
$128M6.1%4.7MNew position1 of 6
3
RLAY
Relay Therapeutics Inc
$127M6.0%6.8M+1.3M (+23%)6 of 6
4
TYRA
Tyra Biosciences Inc
$114M5.4%3.6M−502K (−12%)6 of 6
5
ALMS
Alumis Inc
$99.6M4.7%3.5MNo change6 of 6
6
ORIC
Oric Pharmaceuticals Inc
$77.6M3.7%7.2MNo change6 of 6
7
KYMR
Kymera Therapeutics Inc
$32M1.5%279KNo change5 of 6
8
ZYME
Zymeworks Inc
$29.1M1.4%1.1MNo change6 of 6
9
GLUE
Monte Rosa Therapeutics Inc
$18.4M0.9%761K+457K (+150%)3 of 6
10
ARVN
Arvinas Inc
$17.1M0.8%1.1M+583K (+108%)6 of 6
🔒 5 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q1 2026, gone in Q2 2026
StockValue last quarterShares sold
TNGX
Tango Therapeutics Inc
$152M7.3M
CGEM
Cullinan Therapeutics Inc
$16.2M1.1M
ENGENE HOLDINGS INC
$15.8M2.3M
SPRY
Ars Pharmaceuticals Inc
$4.9M611K

Reported value

last 6 quarters
$430MQ1 '25
$528MQ2 '25
$657MQ3 '25
$1BQ4 '25
$1.4BQ1 '26
$2.1BQ2 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q2 2026

straight from the SEC
FiledFormQuarter
Aug 14, 202613F-HRQ2 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Nextech Invest 13F FAQ

What does Nextech Invest own?

Nextech Invest reported 15 stocks worth $2.1B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are RVMD (67.5%), PBLS (6.1%) and RLAY (6.0%). The table above lists every position in the filing (the top 10 without an account).

What did Nextech Invest buy and sell in Q2 2026?

Compared with Q1 2026: 2 new positions, 3 added to, 1 trimmed and 4 sold out. New positions include PBLS and ENGN. It sold all of TNGX, CGEM and SPRY.

When will Nextech Invest file its next 13F?

Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.

How much is Nextech Invest's portfolio worth?

The Q2 2026 filing reports $2.1B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.